AnaptysBio Inc (ANAB) — Long-term Investment Intensity
AnaptysBio Inc (ANAB) has a Long-term Investment Intensity of 2.2% as of September 2025. Long-term investments of $7.70 Million represent 2.2% of total assets of $353.10 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check AnaptysBio Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
AnaptysBio Inc Long-term Investment Intensity (2017–2024)
This chart shows how AnaptysBio Inc's Long-term Investment Intensity has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the intensity stands at 2.2%, reflecting long-term investments of $7.70 Million against total assets of $353.10 Million USD. Explore AnaptysBio Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for AnaptysBio Inc (2017–2024)
The table below presents the year-by-year Long-term Investment Intensity for AnaptysBio Inc from 2017 to 2024, covering 8 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see ANAB stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 7.3% | $35.47 Million | $483.83 Million | ▲ +1.4 pp |
| 2023 | 6.0% | $27.03 Million | $452.39 Million | ▼ -17.4 pp |
| 2022 | 23.4% | $142.94 Million | $610.38 Million | ▲ +13.0 pp |
| 2021 | 10.4% | $67.10 Million | $643.07 Million | ▲ +6.2 pp |
| 2020 | 4.2% | $17.55 Million | $416.55 Million | ▼ -8.3 pp |
| 2019 | 12.5% | $54.30 Million | $435.20 Million | ▼ -1.9 pp |
| 2018 | 14.4% | $73.13 Million | $509.00 Million | ▼ -8.7 pp |
| 2017 | 23.0% | $75.90 Million | $329.36 Million | — |